Health CarePharmaceuticals & Biotechnology
  • Price (GBX)2,201.00
  • Today's Change-4.00 / -0.18%
  • Shares traded37.98k
  • 1 Year change8.80%
  • Beta0.5316
Data delayed at least 20 minutes, as of Oct 18 2017 15:17 BST.
More ▼

Key statistics

As of last trade Genus PLC (GNS:LSE) traded at 2,201.00, -2.91% below its 52-week high of 2,267.00, set on Oct 12, 2017.
52-week range
1,652.00Jul 25 20172,267.00Oct 12 2017
Markit short selling activity
Previous close2,205.00
Average volume62.99k
Shares outstanding61.17m
Free float60.80m
P/E (TTM)41.65
Market cap1.35bn GBP
EPS (TTM)0.5295
Annual div (ADY)23.60
Annual div yield (ADY)1.07%
Div ex-dateMar 02 2017
Div pay-dateMar 31 2017
Next div ex-dateNov 16 2017
Next div pay-dateDec 01 2017
Data delayed at least 20 minutes, as of Oct 18 2017 15:17 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Genus PLC shares was Hold at 1,932.00 on 11 Sep 2017Read the full article

Board of Directors


Bob Lawson, Non-Executive Chairman


Karim Bitar, Chief Executive


Stephen Wilson, Group Finance Director


Nigel Turner, Senior Non-Executive Director


Lysanne Gray, Non-Executive Director


Prof.Duncan Maskell, Non-Executive Director


Lykele van der Broek, Non-Executive Director


Dan Hartley, Group General Counsel and Company Secretary

Investor Relations Contact

Registered Office:

Genus plc

Matrix House

Basing View



RG21 4DZ

Registered number: 2972325

Telephone: +44(0)1256 347100

Fax: +44 (0)1256 477385

Genus - Preliminary Results 2017

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.